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Abstract
Background: The condition of obesity has become a significant public health problem in the United
States. In children and adolescents, the prevalence of overweight has tripled in the last 20 years, with
approximately 16.0% of children ages 6–19, and 10.3% of 2–5 year olds being considered overweight.
Considerable research is underway to understand obesity in the general pediatric population, however
little research is available on the prevalence of obesity in children with developmental disorders. The
purpose of our study was to determine the prevalence of overweight among a clinical population of
children diagnosed with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders
(ASD).
Methods: Retrospective chart review of 140 charts of children ages 3–18 years seen between 1992 and
2003 at a tertiary care clinic that specializes in the evaluation and treatment of children with
developmental, behavioral, and cognitive disorders. Diagnostic, medical, and demographic information was
extracted from the charts. Primary diagnoses of either ADHD or ASD were recorded, as was information
on race/ethnicity, age, gender, height, and weight. Information was also collected on medications that the
child was taking. Body mass index (BMI) was calculated from measures of height and weight recorded in
the child's chart. The Center for Disease Control's BMI growth reference was used to determine an age-
and gender-specific BMI z-score for the children.
Results: The prevalence of at-risk-for-overweight (BMI >85th%ile) and overweight (BMI > 95th%ile) was
29% and 17.3% respectively in children with ADHD. Although the prevalence appeared highest in the 2–
5 year old group (42.9%ile), differences among age groups were not statistically significant. Prevalence did
not differ between boys and girls or across age groups (all p > 0.05). For children with ASD, the overall
prevalence of at-risk-for-overweight was 35.7% and prevalence of overweight was 19%.
Conclusion: When compared to an age-matched reference population (NHANES 1999–2002), our
estimates indicate that children with ADHD and with ASD have a prevalence of overweight that is similar
to children in the general population.
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Background
The condition of obesity has become a significant public
health problem in the United States. Since 1980, the prev-
alence of obesity in adults has almost doubled, with cur-
rent estimates of obesity present in over 35% of adults [1].
In children and adolescents, the prevalence of overweight
has tripled in the last 20 years, with approximately 16.0%
of children ages 6 through 19, and 10.3% of 2–5 year olds
being considered overweight [1]. It should be noted that
the terminology used to describe the condition of obesity
differs between adults and children. For children, an
expert committee on pediatric obesity [2] has recom-
mended that the following terms be used to classify BMI
(body mass index) cut-off points: children who have a
BMI greater than or equal to the 85th percentile ( ≥ 85%)
are referred to as at-risk-for-overweight; children whose BMI
is at or above the 95th percentile ( ≥ 95%) are referred to
as overweight. The term obesity is avoided in the categoriza-
tion of weight status for children, which reflects the fact
that BMI is not a direct measure of fatness and that misla-
beling of a child as obese is potentially harmful [2].
The reasons for the alarming increase in prevalence of
overweight in children are not well understood, but
changes in demographics, family structure, lifestyle
choices, decreases in physical activity, greater accessibility
to food and increased portion sizes, as well as cultural/
media influences are assumed to play a role [3]. The con-
sequences of childhood obesity are significant; childhood
obesity is associated with an increased risk for type 2 dia-
betes, orthopedic problems, sleep apnea, elevated cardio-
vascular risk factor levels, and menstrual irregularities [4].
Many overweight children already exhibit impaired glu-
cose tolerance [5]. The likelihood of childhood obesity
persisting into adulthood is increased with greater severity
and younger age of onset [6].
Some research has been conducted to examine the preva-
lence of obesity in children with developmental disabili-
ties, particularly in individuals with Down syndrome and
Prader-Willi syndrome who are reported to have a higher
prevalence of overweight than in the general population
[7-9]. However, few studies have been undertaken to
assess the prevalence of overweight in children with other
developmental disorders, such as attention deficit hyper-
activity disorder (ADHD) and autism spectrum disorders
(ASD). Our clinical observations suggest that these chil-
dren may be at increased risk for overweight due to fewer
opportunities to engage in structured physical activity,
social isolation, increased sedentary behavior such as tel-
evision viewing or computer time, and unusual dietary
patterns.
Attention Deficit Hyperactivity Disorder (ADHD) is one
of the most common neurodevelopmental/behavioral
disorders of childhood. The core features of this disorder
include developmentally inappropriate levels of inatten-
tion, impulsivity, distractibility, and motoric overactivity
(or hyperactivity). These behaviors cause functional
impairment that is commonly seen across settings, such as
school, home, and with peers [10]. Children with ADHD
have academic, behavioral, and social/emotional difficul-
ties that frequently require psychopharmacologic, educa-
tional, and psychosocial interventions.
Autism is a neurologically-based developmental disorder
which appears in childhood, usually by the age of 3 years.
As defined by the Diagnostic and Statistical Manual of
Mental Disorders, 4th  edition (DSM-IV), autism falls
under the broad diagnostic category of Pervasive Develop-
mental Disorders and is marked by impairments in com-
munication, forming relationships/social interaction, and
often behavioral control [10]. The diagnostic categories of
autistic disorder, PDD-NOS and Asperger's syndrome are
considered to constitute a "spectrum" of autism and share
many characteristics such as delayed speech/language
development, delayed or unusual play routines, and ster-
eotypic behaviors (e.g., spinning, hand flapping), narrow
ranges of interest, and a tendency to display rigid and/or
perseverative behavioral repertoires. Thus, the term
Autism Spectrum Disorders (ASD) is used to characterize
the continuum of children with these difficulties.
The aim of this study was to determine the prevalence of
overweight among children diagnosed with ADHD and
Autism Spectrum Disorders (ASD) seen in a tertiary care
clinic.
Methods
We reviewed patient records from a tertiary care clinic at
the Tufts-New England Medical Center in Boston, MA that
specializes in the evaluation and treatment of children
with developmental, behavioral, and cognitive disorders.
We selected every 5th chart from the files available at the
clinic to enable us to obtain a representative sample of
clinic patients. To select charts of children seen recently,
we selected the charts of patients seen for initial visit or for
follow-up between 2002 and 2003. Each chart was
reviewed for the presence of the diagnosis of ADHD or
ASD. If the chart did not contain this diagnosis, the next
5th chart was chosen. Of the charts drawn that contained
these diagnoses, we included only charts with complete
information on height, weight, and age; this yielded a
final total of 140 charts. Ninety-eight (98) charts
belonged to children who had a diagnosis of Attention
Deficit Hyperactivity Disorder (ADHD) and 42 charts
belonged to children who had Autism Spectrum Disorder
(ASD).BMC Pediatrics 2005, 5:48 http://www.biomedcentral.com/1471-2431/5/48
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Diagnostic, medical, and demographic information was
extracted from each chart. Patients seen at the clinic
undergo comprehensive evaluations in which the child
and his/her parent(s) are interviewed extensively for a
detailed history that includes information about birth,
medical, developmental, school, family, and psychosocial
histories. The child's parents are asked to provide back-
ground records and school reports as well as to complete
behavior rating scales. The child's teachers are also asked
to complete behavior rating scales in order to confirm that
symptoms are occurring in the school setting as well as at
home. Each child undergoes a thorough physical, neuro-
logical, and developmental examination. In many cases,
children are also seen for neuropsychological, speech/lan-
guage and educational evaluations. The diagnoses of
ADHD and ASD are made using DSM-IV criteria and addi-
tional testing data. For this chart review, primary diag-
noses of either ADHD or ASD were recorded, as was
information on race/ethnicity, date of birth, gender,
height, and weight. We also collected information on
medications that the child was taking. Children were seen
at various intervals for follow-up visits, therefore we used
data obtained from the child's initial visit at the clinic.
Body mass index (BMI) was calculated from measures of
height and weight indicated in the child's chart, taken by
a physician or nurse at the time of the first visit. The
Center for Disease Control's BMI growth reference was
used to determine an age- (to the nearest month) and gen-
der-specific BMI z-score for the children. Age was calcu-
lated based on date of birth and the date of the visit. We
used z-scores corresponding to the 85th (at-risk-for-over-
weight) and 95th percentiles (overweight) of BMI as cut
points to classify overweight [11]. The study protocol was
approved by the hospital's Institutional Review Board and
exempted from informed consent.
Prevalence estimates by gender and age group were com-
pared within diagnosis by chi-square or by Fisher's Exact
test, for any analysis with a count in a cell of fewer than 5.
Prevalence estimates and their 95% confidence intervals
(CI) were used to compare our estimates to population
estimates of prevalence based on the most recently availa-
ble national data, the National Health and Nutrition
Examination Survey 1999–2002 [1]. Where the 95% CI
included the national estimates, we concluded that esti-
mates did not differ. Statistical significance was deemed
present when p < 0.05. Because the information obtained
was at the child's initial visit, the data we gathered spread
over a period of 11 years (1992–2003). Because there
have been secular increases in the prevalence of obesity,
using the NHANES 1999–2002 prevalence estimates for
comparison constitutes a conservative approach.
Results
Children with ADHD
Child characteristics are presented in Table 1. Eighty-one
percent (81%) of the children with ADHD were white, 7%
were African American, 3% were Hispanic, 8% were Asian,
and 1% were of other race/ethnicity. Eighty-one percent
(81%) were boys and 19% were girls. The majority of chil-
dren with ADHD (59.2%) were between 6–11 years of
age.
The prevalence of at-risk-for-overweight was 29% in chil-
dren with ADHD (Table 2) and did not differ significantly
between boys and girls (31% vs. 25.9%). The prevalence
appeared highest in the 2–5 year old group (42.9%), but
differences among age groups were not statistically signif-
icant.
The prevalence of overweight in children with ADHD was
17.3%. Prevalence estimates of boys and girls and across
age groupings were not significantly different. When our
estimates are compared to an age-matched reference pop-
ulation (NHANES 1999–2002) [12], children with ADHD
have a prevalence of overweight that does not differ from
children in the general population.
Medication use
Because the use of stimulant medication is common
among children with ADHD and may influence weight
stability, we examined the relationship of stimulant med-
ication use to weight status (Table 3). Thirty-three percent
(33%) of the 98 children with ADHD whose charts we
reviewed were receiving stimulant medication at the ini-
tial visit. Of these children, 5 (16%) were considered at-
Table 1: Demographic characteristics of age, gender and race/
ethnicity of charts reviewed for children with ADHD and ASD at 
an ambulatory care clinic.
ADHD ASD
N = 98 N = 42
Age (y)
2–5 14.3% (14) 50% (21)
6–11 59.2% (58) 38% (16)
12–18 26.5% (26) 12% (5)
Gender
Male 81% (79) 81% (34)
Female 19% (19) 19% (8)
Race/Ethnicity
White 81% (79) 83.3% (35)
African American 7% (7) 0 (0)
Hispanic 3% (3) 4.8% (2)
Asian 8% (8) 9.5% (4)
Other race/ethnicity 1% (1) 2.4% (1)
( ) = no. of subjectsBMC Pediatrics 2005, 5:48 http://www.biomedcentral.com/1471-2431/5/48
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risk-for-overweight and 2 (6.3%) were overweight. In
comparison, 24 (36%) of the children who were not
receiving stimulant medication were at-risk-for-over-
weight and 15 (23%) were classified as overweight. These
differences are statistically significant (p < 0.05, Fisher's
Exact test). Interestingly, none of the children taking stim-
ulant medications were underweight (i.e., below the 15th
percentile), although 5 (16%) of the children not receiving
stimulant medication were underweight.
Small numbers of children with ADHD received other
types of medications (Serotonin reuptake inhibitors
(SSRI's) n = 2; anticonvulsants n = 1; anti-hypertensives n
= 7; other antidepressants n = 1; and other medications n
= 5). Because of the small sample sizes we were not able
to examine these medications in relation to weight status.
Children with Autism Spectrum Disorders (ASD)
Eighty-three percent (83%) of the children with an ASD
diagnosis were white, 5% were Hispanic, 10% were Asian,
and 2% were of other race/ethnicity (Table 1). Eighty-one
percent (81%) were male. In this group, the overall prev-
alence of at-risk-for-overweight was 35.7% and prevalence
of overweight was 19% (Table 4). When stratified by age,
the prevalence of at-risk-for-overweight and overweight
appears to be highest in the 12.0–17.9 year old group,
however differences by age category were not significant.
We were unable to conduct an analysis of medication use
in relation to overweight because only a small number of
children in the ASD sample were on medication, and the
types of medication were quite variable.
Discussion
Our data from this chart review suggest that as for the gen-
eral population of children in the US, overweight repre-
sents a problem among children with ADHD and ASD.
The prevalence of at-risk-for-overweight (BMI ≥ 85th per-
centile) and overweight (BMI ≥ 95th percentile) was 29%
and 17.3% respectively in children with ADHD. For chil-
dren with ASD, the overall prevalence of at-risk-for-over-
weight was 35.7% and prevalence of overweight was 19%.
The literature on obesity in children with ADHD is sparse.
Historically, inquiries into weight status of children with
ADHD have focused on the potential for growth suppres-
sion associated with the use of stimulant medication.
More recently, however, some research has been con-
ducted to examine the prevalence of overweight in chil-
dren with ADHD. Anderson et al. [13] reported an
association of increased relative weight among girls with
ADHD but not boys in a community-based sample.
Holtkamp et al. [14] evaluated a sample of 97 boys with
ADHD in Germany to test the hypothesis that hyperactive
boys would have a lower prevalence of obesity than an
age-matched healthy male reference population. Contrary
to expectations, they found that a significant number of
subjects with ADHD had a BMI ≥ 90th percentile (19.6%)
and 7.2% had a BMI ≥ 97th percentile using the higher
International Obesity Task Force cut-offs points. Altfas et
al. [15] conducted a chart review of 215 adults seen in a
weight control clinic. Among these patients, 90% of
whom were female, 27.4% had ADHD, 33.5% had symp-
toms and behaviors of ADHD but did not meet formal
diagnostic criteria, and 39.1% did not have ADHD. All of
the patients with ADHD were classified as having the inat-
tentive type of the disorder. Of those patients with a BMI
≥ 40, 42.6% had ADHD. The authors noted that patients
with ADHD were less successful at losing weight than
those without ADHD. In a recent study of 26 children,
hospitalized for obesity (BMI>85%) (mean age 13),
Agranat-Meged et al. [16] found that 15 of these children
had ADHD. Nine of these children had not been diag-
nosed prior to the study. Ten of the 13 boys and 5 of the
13 girls were found to have ADHD. Of the 15 children
with ADHD, 9 had the combined type of ADHD and 6
had the inattentive type. Although this study suggests a
relation between ADHD and obesity, the number of
patients was relatively small and the study lacked a com-
parison group.
Although the criteria for overweight may differ among
studies, our data and the reported data to date suggest that
overweight is a problem among children with ADHD. Fur-
thermore, the data reported by Altfas et al. and Agranat-
Meged et al. underscore the importance of understanding
and preventing the problem of overweight in children
with ADHD, before they become adults.
The children in our study taking stimulant medication
were half as likely to be overweight as those not on these
medications however, none of the children in our sample
Table 2: Prevalence (95% confidence interval) of at-risk-for-
overweight ( ≥ 85 percentile)1 and overweight ( ≥ 95 percentile) 
by age in children with ADHD and national estimates.
NHANES 1999–2002* ADHD N = 98
AT RISK
2–5 yr 22.6% 42.9% (16.9, 68.8)
6–11 yr 31.2% 25.9% (14.6, 37.1)
12–19 yr 30.9% 30.8% (13.0, 48.5)
Overall 31.0% 29% (20.0, 38.0)
OVERWEIGHT
2–5 yr 10.3% 21% (0.0, 42.3)
6–11 yr 15.8% 16% (6.6, 25.4)
12–19 yr 16.1% 19% (3.9, 34.0)
Overall 16.0% 17.3% (9.8, 24.8)
1CDC recommended cut-off points for at-risk-for 
overweight and overweight (11). *Hedley et al. JAMA 2004BMC Pediatrics 2005, 5:48 http://www.biomedcentral.com/1471-2431/5/48
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who took stimulant medication were underweight.
Reports in the literature of the effects of stimulant medica-
tion on weight status are equivocal; for example, one
study found weight loss among children taking stimulant
medication [17] whereas another found no weight deficits
[18].
Only a few studies have reported data on weight status of
children with ASD. In one recent report, Mouridsen et al.
[19] examined the weight status of 117 young Danish
children with autism. Body mass index (BMI) for males
but not for females was significantly lower than an age-
matched reference population. In Germany, a low BMI
has been reported in 13 children with Asperger's syn-
drome [20]. In a large study of 20,031 Japanese children
and adolescents with mental retardation (6–17 yrs) that
included 413 children with autism, the prevalence of
obesity was reported to be 22% in boys and 11% in girls.
No data were available to assess the prevalence among dif-
ferent age groups and obesity was defined from measures
of standard weight for height [21]. Another study of 140
Japanese children 7–18 years of age with autism revealed
that 25% of the children were classified as obese [22]. The
variability in the prevalence estimates among children
with autism from different countries may be explained by
different environmental factors that contribute to the
development of overweight. In addition, different defini-
tions of obesity, the diagnostic category, or mode of
recruitment into the studies may contribute to observed
differences. Nonetheless, these data support our findings
that overweight is as significant a problem in children
with autism as in the general population.
For children with ASD, unusual dietary patterns and
decreased access to opportunities for physical activity may
be factors that contribute to overweight. Rosser and Frey
[23] report less time spent in moderate activity in children
with ASD compared to children without ASD. Opportuni-
ties to engage in structured activities may be limited and
may further decline with age for children with ASD. In our
study, although the numbers in each age group are small,
we observed a trend toward increasing prevalence of over-
weight with increasing age for children with ASD. Further
research is needed to determine whether the prevalence of
obesity in children with ASD increases with age and
whether differences in eating and activity patterns contrib-
ute to overweight. Identification of specific environmen-
tal factors that are associated with increasing the risk for
overweight (e.g., access to physical activity programs, time
spent in sedentary behavior) are important areas of
research that will help direct efforts at health promotion
and disease prevention for this population of children.
Our study data were obtained from a chart review at a ter-
tiary care clinic, hence, the data gathered represent chil-
dren from a special population. Therefore, our findings
may not be generalizable to the broader community of
children with ADHD, and should be considered prelimi-
nary. Furthermore, because we relied on clinically derived
diagnoses of ADHD and ASD rather than on objective,
standardized measures, we are unable to determine the
diagnostic homogeneity of the clinical charts reviewed.
We chose to look at data at the initial visit, thus additional
diagnostic information that may have surfaced on subse-
quent visits, such as the presence of depression, a known
risk factor in ADHD was unavailable. Because depression
is a frequent co-morbidity in children with ADHD and has
been shown to be related to obesity [24-26] depression
Table 3: Prevalence of at-risk-for-overweight( ≥ 85th %ile)1and overweight ( ≥ 95th %ile) in children with ADHD receiving stimulants 
medication to those not receiving stimulant medication.
Receiving 
stimulant 
medication
All Subjects Underweight <15th 
percentile
Healthy Weight 
15th to 85th 
percentile
At Risk 85th to 95th 
percentile
Overweight >95th 
percentile
YES 33% (32) 0 78% (25) 16% (5) 6% (2)
NO 67% (66) 8% (5) 33% (22) 36% (24) * 23% (15) *
Total 100% (98) 5% (5) 48% (47) 30% (29) 17% (17)
1CDC recommended cut-off points for at-risk-for overweight and overweight (11). Fisher Exact Test (p < .05)
Table 4: Prevalence (95% confidence interval) of at-risk-for-
overweight ( ≥ 85 percentile)1 and overweight ( ≥ 95 percentile) 
by age in children with Autism Spectrum Disorders
*NHANES 
1999–2000
AUTISM SPECTRUM 
DISORDERS (ASD) N = 42
AT-RISK-FOR-OVERWEIGHT
2–5 yr 22.6% 23.8% (5.6, 42.0)
6–11 yr 31.2% 37.8% (14.0, 61.6)
12–19 yr 30.9% 80% (44.9, 100.0+)
Overall 31.0% 35.7% (21.2, 50.2)
OVERWEIGHT
2–5 yr 10.3% 14.2% (0.0, 29.1)
6–11 yr 15.8% 18.8% (0.0, 37.9)
12–19 yr 16.1% 50% (6.1, 93.8)
Overall 16.0% 19.0% (7.1, 30.1)
1CDC recommended cut-off points for at-risk-for overweight 
and overweight (11). * Hedley et al. JAMA 2004BMC Pediatrics 2005, 5:48 http://www.biomedcentral.com/1471-2431/5/48
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may have been a confounding factor. Thus, larger studies
of children with ADHD and ASD adjusting for co-morbid
conditions need to be carried out to elucidate further
these findings. Finally, the number of charts reviewed was
small, so our prevalence estimates lack a high degree of
precision.
Conclusion
As noted, data from this chart review suggest that just as
overweight is a problem for the general population of
children in the US, overweight also represents a problem
among children with ADHD and ASD. The prevalence of
at-risk-for-overweight (BMI ≥ 85th percentile) and over-
weight (BMI ≥ 95th  percentile) was 29% and 17.3%
respectively in children with ADHD. For children with
ASD, the overall prevalence of at-risk-for-overweight was
35.7% and prevalence of overweight was 19%.
Despite noted limitations, our data suggest that the prob-
lem of overweight in children with ADHD and ASD is at
least as significant as in the general population. Factors
that contribute to the development of overweight or its
maintenance in this population of children may be differ-
ent than in children without these disorders, and there-
fore warrant further investigation. Furthermore, the
burden of managing potential co-morbidities associated
with obesity may be particularly problematic for children
with developmental disorders and their families, and may
limit options for living independently in adulthood.
Therefore, this area of research warrants focused attention
and effort.
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